Spots Global Cancer Trial Database for Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Official Title: A Phase II Clinical Trial of Pembrolizumab in Combination With Carboplatin-paclitaxel in Patients With Advanced (Stage III B-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer: MITO28/MANGO OV4 Study
Study ID: NCT03410784
Conditions
Study Description
Brief Summary: This study is designed to assess the therapeutic efficacy and toxicity of the combination chemotherapy Paclitaxel and Carboplatin with Pembrolizumab in patients with advanced ovarian cancer. The main objective is to test whether the therapeutic intervention benefits the patient evaluating the number of subjects who are progression-free after 18 months from the beginning of the first line treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Ospedale Generale Regionale "F. Miulli ", Acquaviva delle Fonti, , Italy
Istituto Tumori Giovanni Paolo II, Bari, , Italy
Spedali Civili - Università di Brescia, Brescia, , Italy
Ospedale Senatore Antonio Perrino, Brindisi, , Italy
Fondazione del Piemonte per l'Oncologia, Candiolo, , Italy
Istituto Romagnolo per lo Studio e la Cura dei Tumori, Meldola, , Italy
Istituto Nazionale Tumori, MIlano, , Italy
AOU Policlinico Federico II, Napoli, , Italy
AOU Università degli studi della Campania "Luigi Vanvitelli", Napoli, , Italy
Istituto Nazionale dei Tumori, Napoli, , Italy
Ospedale Silvestrini, Perugia, , Italy
Ospedale S. Giovanni Calibita Fatebenefratelli, Roma, , Italy
Policlinico Universitario Gemelli Università Cattolica del Sacro Cuore, Roma, , Italy
Contact Details
Name: Sandro Pignata, M.D., Ph.D.
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR
Name: Nicoletta Colombo, M.D.
Affiliation: European Institute of Oncology
Role: PRINCIPAL_INVESTIGATOR
Name: Francesco Perrone, M.D., Ph.D.
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR
Name: Gennaro Daniele, M.D., Ph.D.
Affiliation: National Cancer Institute, Naples
Role: PRINCIPAL_INVESTIGATOR
Name: Ciro Gallo, M.D.
Affiliation: University of Campania "Luigi Vanvitelli"
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
